Your browser doesn't support javascript.
loading
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity.
Richter, Michelle F; Zhao, Kevin T; Eton, Elliot; Lapinaite, Audrone; Newby, Gregory A; Thuronyi, B W; Wilson, Christopher; Koblan, Luke W; Zeng, Jing; Bauer, Daniel E; Doudna, Jennifer A; Liu, David R.
Afiliação
  • Richter MF; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Zhao KT; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Eton E; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Lapinaite A; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Newby GA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Thuronyi BW; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Wilson C; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Koblan LW; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • Zeng J; Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • Bauer DE; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
  • Doudna JA; School of Molecular Sciences, Arizona State University, Tempe, AZ, USA.
  • Liu DR; Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Nat Biotechnol ; 38(7): 883-891, 2020 07.
Article em En | MEDLINE | ID: mdl-32433547
Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (kapp) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA / RNA / Adenina / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Nat Biotechnol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA / RNA / Adenina / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Nat Biotechnol Ano de publicação: 2020 Tipo de documento: Article